Long-term consequences after exposure to antiepileptic drugs in utero

Lisa Forsberg1, Katarina Wide1

  • 1Astrid Lindgren Children's Hospital at Karolinska University Hospital Huddinge and Department of Clinical Science, Intervention and Technique (CLINTEC), Karolinska Institutet, Stockholm, Sweden.

Insights

Most pregnant women with epilepsy require medication. While some antiepileptic drugs pose risks to fetal development, carbamazepine and lamotrigine monotherapy appear safe for child cognition.

Area of Science:

  • Neurology
  • Pharmacology
  • Developmental Pediatrics

Background:

  • Epilepsy treatment during pregnancy often necessitates antiepileptic drugs (AEDs).
  • Prenatal exposure to AEDs is associated with increased risks of major malformations and potential adverse neurodevelopmental outcomes in children.

Purpose of the Study:

  • To evaluate the long-term neurodevelopmental effects of prenatal exposure to specific antiepileptic drugs in children.
  • To compare the safety profiles of monotherapy versus polytherapy AEDs during pregnancy.

Main Methods:

  • Review of existing studies on children exposed to AEDs in utero.
  • Analysis of neurodevelopmental outcomes, including major malformations and cognitive/psychomotor development.

Main Results:

  • Carbamazepine and lamotrigine monotherapy showed no significant negative impact on exposed children's cognition.
  • Valproic acid and polytherapy (two or more AEDs) were linked to negative long-term neurodevelopmental effects.
  • Limited data exist for newer AEDs regarding long-term outcomes.

Conclusions:

  • The choice of AED during pregnancy requires careful consideration of potential risks to fetal development.
  • Monotherapy with certain AEDs like carbamazepine and lamotrigine may be safer for neurodevelopment compared to others or polytherapy.
  • Further research is needed for newer AEDs to ascertain their long-term safety in pregnancy.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K